Who should avoid Tirzepatide: Tirzepatide (Mounjaro, Zepbound) carries similar restrictions and is contraindicated in: Individuals with a personal or family history of MTC Those with MEN 2, due to the same cancer-related concerns People who have experienced severe gastrointestinal issues, such as chronic pancreatitis or gastroparesis Patients with a known hypersensitivity to tirzepatide or any of its components As always, anyone considering these medications should talk with their healthcare provider about their personal health history and risk factors
Pfizer is expected to receive an upfront sum of $200 million from the company
Metabolic syndrome: Also referred to as insulin resistance syndrome, this group of illnesses raises the risk of heart attacks, strokes, and diabetes
In accordance with the FISH results, we observed some very intensely labeled GLP-1R + but ChAT-negative neurons in the IML in the upper- and mid-thoracic segments (Fig
This personalized insight, available as a $99 add-on after your first month of treatment, eliminates guesswork and optimizes your nutrition strategy
Retatrutide, also known as LY3437943, is a "triple G" or GGG tri-agonist